Patient portal use linked to improved adherence

Patients with diabetes who regularly refilled their prescriptions using Kaiser Permanente’s (KP’s) patient portal improved their medication adherence and lowered their cholesterol levels, according to a study published in Medical Care.

In the study, funded by the National Institutes of Health, researchers from KP and the University of California, San Francisco Medical followed a diverse sample of 17,760 patients with diabetes who received care from KP in Northern California between January 2006 and December 2010. All patients had been prescribed cholesterol-lowering medications.

Researchers found that medication non-adherence and poorly controlled cholesterol decreased by 6 percent among patients using the portal compared to occasional or non-users.

"This research is an important step in understanding the benefits of portals beyond convenience. Given the clear connection between medication adherence and improved health outcomes, this study provides insight into how online portals may improve health outcomes," said lead author Urmimala Sarkar, MD, an assistant professor at University of California San Francisco.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.